Trials / Active Not Recruiting
Active Not RecruitingNCT03569956
Shaving Satisfaction in Males With Skin Irritation From Shaving
The Impact of the 556 Razor Technology and of a Regimen of the 556 Razor Technology With Pre-Shave Gel and Brush on Shaving Satisfaction in Males With Skin Irritation From Shaving
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Wake Forest University Health Sciences · Academic / Other
- Sex
- Male
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research study is to evaluate the improvement in overall shave satisfaction, the appearance of skin irritation from shaving, and the razor related inflammation of the hair follicles when using a new razor technology in a regular shaving regimen as well as a new razor technology in a shaving regimen that includes a pre-shave gel, cleansing brush and shaving gel.
Detailed description
A secondary objective is to show improvement in the satisfaction of the shaving experience, symptoms such as bumps and irritation, and quality of life (QOL), when adding the 556 Razor, or the 556 Razor with a regimen of pre-shave gel, cleansing brush, and shave gel to the shaving regimen of males with shaving skin irritation. Shaving irritation severity will be correlated to shave satisfaction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 556 Razor | In the Razor group, subjects will use the 556 Razor with their regular shaving products, and shave at least 5 or more times per week. In the Regimen group, subjects will use the 556 Razor, Pre-Shave Gel, Cleansing brush and Shaving Gel, and shave at least 5 or more times per week. All subjects will be given the 556 Razors during the 12-week study. The Regimen group will also be given the Pre-Shave Gel, Cleansing Brush, and Shaving Gel. |
Timeline
- Start date
- 2018-10-29
- Primary completion
- 2019-04-30
- Completion
- 2026-04-01
- First posted
- 2018-06-26
- Last updated
- 2025-12-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03569956. Inclusion in this directory is not an endorsement.